論文・総説 - 蘇原　映誠

41. Suzuki Soichiro, Naito Shotaro, Numasawa Yoshiyuki, Asada Mizuho, Shoji Norikazu, Zeniya Moko, Takahashi Daiei, Sato Hidehiko, Iimori Soichiro, Nomura Naohiro, Sohara Eisei, Okado Tomokazu, Ishiwata Yasuyoshi, Nagata Masashi, Rai Tatemitsu, Yokota Takanori, Uchida Shinichi. Encephalopathy Induced by High Plasma and Cerebrospinal Fluid Ceftriaxone Concentrations in a Hemodialysis Patient(和訳中) Internal Medicine. 2019.06; 58 (12): 1775-1779. ( 医中誌 )

42. Sakoh T, Sekine A, Mori T, Mizuno H, Kawada M, Hiramatsu R, Hasegawa E, Hayami N, Yamanouchi M, Suwabe T, Sawa N, Ubara Y, Fujimaru T, Sohara E, Shinichi U, Hoshino J, Takaichi K. A familial case of pseudohypoaldosteronism type II (PHA2) with a novel mutation (D564N) in the acidic motif in WNK4. Molecular genetics & genomic medicine. 2019.06; 7 (6): e705. ( PubMed, DOI )

43. Ohkubo Atsushi, Okado Tomokazu, Sakurasawa Takatoshi, Maeda Takuma, Itagaki Ayako, Yamamoto Hiroko, Miyamoto Satoko, Seshima Hiroshi, Kurashima Naoki, Mori Takayasu, Iimori Soichiro, Sohara Eisei, Rai Tatemitsu, Uchida Shinichi, Naito Shotaro. Removal Characteristics of Immunoadsorption with the Tryptophan-Immobilized Column Using Conventional and Selective Plasma Separators in the Treatment of Myasthenia Gravis(和訳中) Therapeutic Apheresis and Dialysis. 2019.06; 23 (3): 271-278. ( 医中誌 )

44. Sohara Eisei, Kikuchi Hiroaki, Uchida Shinichi. 腎機能の再生医療におけるNew Frontiers　慢性腎臓病におけるエネルギー状態感知不全(New Frontiers in Regenerative Medicine of Renal Function　Failure to sense energy depletion in chronic kidney disease) The Journal of Physiological Sciences. 2019.06; 69 (Suppl.1): S56. ( 医中誌 )

45. Tanaka T, Oki E, Mori T, Tsuruga K, Sohara E, Uchida S, Tanaka H. Complete clinical resolution of a Japanese family with renal pseudohypoaldosteronism type 1 due to a novel NR3C2 mutation. Nephrology (Carlton, Vic.). 2019.04; 24 (4): 489-490. ( PubMed, DOI )

46. Sekine A, Fujimaru T, Hoshino J, Suwabe T, Oguro M, Mizuno H, Kawada M, Sumida K, Hiramatsu R, Hasegawa E, Yamanouchi M, Hayami N, Mandai S, Chiga M, Kikuchi H, Ando F, Mori T, Sohara E, Uchida S, Sawa N, Takaichi K, Ubara Y. Genotype-Clinical Correlations in Polycystic Kidney Disease with No Apparent Family History. American journal of nephrology. 2019.02; 49 (3): 233-240. ( PubMed, DOI )

47. Suzuki S, Naito S, Numasawa Y, Asada M, Shoji N, Zeniya M, Takahashi D, Sato H, Iimori S, Nomura N, Sohara E, Okado T, Ishiwata Y, Nagata M, Rai T, Yokota T, Uchida S. Encephalopathy Induced by High Plasma and Cerebrospinal Fluid Ceftriaxone Concentrations in a Hemodialysis Patient. Internal medicine (Tokyo, Japan). 2019.02; ( PubMed, DOI )

48. Watanabe S, Ino J, Fujimaru T, Taneda S, Akihisa T, Makabe S, Kataoka H, Mori T, Sohara E, Uchida S, Nitta K, Mochizuki T. <i>PKD1</i> mutation may epistatically ameliorate nephronophthisis progression in patients with <i>NPHP1</i> deletion. Clinical case reports. 2019.02; 7 (2): 336-339. ( PubMed, DOI )

49. Kikuchi H, Sasaki E, Nomura N, Mori T, Minamishima YA, Yoshizaki Y, Takahashi N, Furusho T, Arai Y, Mandai S, Yamashita T, Ando F, Maejima Y, Isobe K, Okado T, Rai T, Uchida S, Sohara E. Failure to sense energy depletion may be a novel therapeutic target in chronic kidney disease. Kidney international. 2019.01; 95 (1): 123-137. ( PubMed, DOI )

50. Yoshida Sayaka, Araki Yuya, Mori Takayasu, Sasaki Emi, Kasagi Yuri, Isobe Kiyoshi, Susa Koichiro, Inoue Yuichi, Bomont Pascale, Okado Tomokazu, Rai Tatemitsu, Uchida Shinichi, Sohara Eisei. Decreased KLHL3 expression is involved in the pathogenesis of pseudohypoaldosteronism type II caused by cullin 3 mutation in vivo Clinical and Experimental Nephrology. 2018.12; 22 (6): 1251-1257. ( 医中誌 )

51. Matsumoto A, Matsui I, Mori T, Sakaguchi Y, Mizui M, Ueda Y, Takahashi A, Doi Y, Shimada K, Yamaguchi S, Kubota K, Hashimoto N, Oka T, Takabatake Y, Sohara E, Hamano T, Uchida S, Isaka Y. A Case of Severe Osteomalacia with Dent Disease Caused by a Novel Intronic Mutation of the CLCN5 gene. Internal medicine (Tokyo, Japan). 2018.08; ( PubMed, DOI )

52. Yamauchi T, Doi S, Nakashima A, Doi T, Sohara E, Uchida S, Masaki T. Na-Cl cotransporter-mediated chloride uptake contributes to hypertension and renal damage in aldosterone-infused rats. American journal of physiology. Renal physiology. 2018.08; 315 (2): F300-F312. ( PubMed, DOI )

53. Hashimoto H, Nomura N, Shoda W, Isobe K, Kikuchi H, Yamamoto K, Fujimaru T, Ando F, Mori T, Okado T, Rai T, Uchida S, Sohara E. Metformin increases urinary sodium excretion by reducing phosphorylation of the sodium-chloride cotransporter. Metabolism: clinical and experimental. 2018.08; 85 23-31. ( PubMed, DOI )

54. Fujimaru T., Mori T., Sekine A., Mandai S., Chiga M., Kikuchi H., Ando F., Mori Y., Nomura N., Iimori S., Naito S., Okado T., Rai T., Hoshino J., Ubara Y., Uchida S., Sohara E.. Kidney enlargement and multiple liver cyst formation implicate mutations in PKD1/2 in adult sporadic polycystic kidney disease CLINICAL GENETICS. 2018.07; 94 (1): 125-131. ( PubMed, DOI )

55. Yoshida S, Araki Y, Mori T, Sasaki E, Kasagi Y, Isobe K, Susa K, Inoue Y, Bomont P, Okado T, Rai T, Uchida S, Sohara E. Decreased KLHL3 expression is involved in the pathogenesis of pseudohypoaldosteronism type II caused by cullin 3 mutation in vivo. Clinical and experimental nephrology. 2018.06; ( PubMed, DOI )

56. Mandai S, Mori T, Nomura N, Furusho T, Arai Y, Kikuchi H, Sasaki E, Sohara E, Rai T, Uchida S. WNK1 regulates skeletal muscle cell hypertrophy by modulating the nuclear localization and transcriptional activity of FOXO4. Scientific reports. 2018.06; 8 (1): 9101. ( PubMed, DOI )

57. Miyamoto S, Ohkubo A, Seshima H, Yamamoto H, Itagaki A, Maeda T, Kurashima N, Mori T, Iimori S, Naito S, Sohara E, Rai T, Uchida S, Okado T. Removal Dynamics of Autoantibodies, Immunoglobulins, and Coagulation Factors by Selective Plasma Exchange on Three Consecutive Days. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 2018.06; 22 (3): 255-260. ( PubMed, DOI )

58. Miyamoto Satoko, Ohkubo Atsushi, Seshima Hiroshi, Yamamoto Hiroko, Itagaki Ayako, Maeda Takuma, Kurashima Naoki, Mori Takayasu, Iimori Soichiro, Naito Shotaro, Sohara Eisei, Rai Tatemitsu, Uchida Shinichi, Okado Tomokazu. Removal Dynamics of Autoantibodies, Immunoglobulins, and Coagulation Factors by Selective Plasma Exchange on Three Consecutive Days(和訳中) Therapeutic Apheresis and Dialysis. 2018.06; 22 (3): 255-260. ( 医中誌 )

59. Toriu N, Mizuno H, Sawa N, Sumida K, Suwabe T, Hayami N, Sekine A, Yamanouchi M, Hoshino J, Takaichi K, Yanagita M, Fujimaru T, Mori T, Sohara E, Uchida S, Ubara Y. Everolimus Reduces the Size of Tuberous Sclerosis Complex-Related Huge Renal Angiomyolipomas Exceeding 20 cm in the Longest Diameter. Case reports in oncology. 2018.05; 11 (2): 258-267. ( PubMed, DOI )

60. Ando F, Mori S, Yui N, Morimoto T, Nomura N, Sohara E, Rai T, Sasaki S, Kondo Y, Kagechika H, Uchida S. AKAPs-PKA disruptors increase AQP2 activity independently of vasopressin in a model of nephrogenic diabetes insipidus. Nature communications. 2018.04; 9 (1): 1411. ( PubMed, DOI )